Nomura Holdings’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.3M | Buy |
36,993
+11,753
| +47% | +$2.93M | 0.02% | 472 |
|
|
2025
Q4 | $6.08M | Buy |
25,240
+3,363
| +15% | +$860K | 0.01% | 715 |
|
|
2025
Q3 | $5.99M | Buy |
+21,877
| New | +$5.98M | 0.01% | 699 |
|
|
2025
Q2 | – | Sell |
-20,549
| Closed | -$4.6M | – | 1875 |
|
|
2025
Q1 | $4.6M | Buy |
20,549
+15,708
| +324% | +$3.67M | 0.01% | 741 |
|
|
2024
Q4 | $1.11M | Buy |
+4,841
| New | +$1.17M | ﹤0.01% | 1407 |
|
|
2024
Q3 | – | Sell |
-2,127
| Closed | -$407K | – | 1931 |
|
|
2024
Q2 | $407K | Buy |
2,127
+952
| +81% | +$193K | ﹤0.01% | 1375 |
|
|
2024
Q1 | $233K | Sell |
1,175
-1,783
| -60% | -$327K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $509K | Sell |
2,958
-2,542
| -46% | -$391K | ﹤0.01% | 1341 |
|
|
2023
Q3 | $813K | Buy |
+5,500
| New | +$994K | ﹤0.01% | 1019 |
|
|
2023
Q2 | – | Sell |
-1,058
| Closed | -$232K | – | 1594 |
|
|
2023
Q1 | $232K | Sell |
1,058
-2,169
| -67% | -$471K | ﹤0.01% | 1216 |
|
|
2022
Q4 | $671K | Buy |
+3,227
| New | +$709K | ﹤0.01% | 915 |
|
|
2022
Q3 | – | Sell |
-2,075
| Closed | -$448K | – | 1924 |
|
|
2022
Q2 | $448K | Buy |
+2,075
| New | +$442K | ﹤0.01% | 1142 |
|
|
2022
Q1 | – | Sell |
-2,805
| Closed | -$731K | – | 2352 |
|
|
2021
Q4 | $731K | Sell |
2,805
-582
| -17% | -$151K | ﹤0.01% | 1314 |
|
|
2021
Q3 | $888K | Buy |
3,387
+867
| +34% | +$237K | ﹤0.01% | 1171 |
|
|
2021
Q2 | $621K | Buy |
2,520
+1,057
| +72% | +$222K | ﹤0.01% | 1241 |
|
|
2021
Q1 | $284K | Sell |
1,463
-3,778
| -72% | -$758K | ﹤0.01% | 1521 |
|
|
2020
Q4 | $1.11M | Buy |
5,241
+1,645
| +46% | +$328K | ﹤0.01% | 996 |
|
|
2020
Q3 | $616K | Buy |
+3,596
| New | +$664K | ﹤0.01% | 937 |
|
|
2020
Q1 | – | Sell |
-3,957
| Closed | -$613K | – | 1184 |
|
|
2019
Q4 | $613K | Buy |
+3,957
| New | +$570K | ﹤0.01% | 876 |
|
|
2019
Q3 | – | Sell |
-5,000
| Closed | -$617K | – | 1372 |
|
|
2019
Q2 | $617K | Buy |
+5,000
| New | +$554K | ﹤0.01% | 917 |
|
|
2018
Q2 | – | Sell |
-11,249
| Closed | -$1.11K | – | 1529 |
|
|
2018
Q1 | $1.11K | Buy |
11,249
+1,717
| +18% | +$162K | ﹤0.01% | 1028 |
|
|
2017
Q4 | $809K | Sell |
9,532
-4,316
| -31% | -$357K | ﹤0.01% | 1180 |
|
|
2017
Q3 | $1.06M | Buy |
+13,848
| New | +$1.06M | ﹤0.01% | 1028 |
|
|
2017
Q2 | – | Sell |
-2,800
| Closed | -$201K | – | 1580 |
|
|
2017
Q1 | $201K | Buy |
+2,800
| New | +$194K | ﹤0.01% | 1178 |
|
|
2016
Q2 | – | Sell |
-12,318
| Closed | -$709K | – | 1555 |
|
|
2016
Q1 | $709K | Buy |
12,318
+7,917
| +180% | +$448K | ﹤0.01% | 776 |
|
|
2015
Q4 | $237K | Buy |
+4,401
| New | +$248K | ﹤0.01% | 1479 |
|
|
2015
Q3 | – | Sell |
-52,317
| Closed | -$2.92M | – | 1901 |
|
|
2015
Q2 | $2.92M | Buy |
+52,317
| New | +$3.3M | 0.01% | 645 |
|
|
2014
Q4 | – | Sell |
-9,623
| Closed | -$475K | – | 2631 |
|
|
2014
Q3 | $475K | Sell |
9,623
-27,458
| -74% | -$1.4M | ﹤0.01% | 1859 |
|
|
2014
Q2 | $1.88M | Buy |
+37,081
| New | +$1.84M | ﹤0.01% | 1152 |
|
|
2014
Q1 | – | Sell |
-15,787
| Closed | -$744K | – | 2877 |
|
|
2013
Q4 | $744K | Sell |
15,787
-88,493
| -85% | -$4.48M | ﹤0.01% | 1110 |
|
|
2013
Q3 | $5.52M | Buy |
104,280
+36,686
| +54% | +$1.78M | 0.03% | 438 |
|
|
2013
Q2 | $3.05M | Buy |
+67,594
| New | +$3.21M | 0.02% | 479 |
|
Other funds holding RMD
VCM
VPM
DAM
Nomura Holdings's RMD Position: Q1 2026 in Review
Nomura Holdings increased its ResMed (RMD) stake by 47% in Q1 2026, buying an estimated $2.93M and bringing the position to 36,993 shares worth $8.3M. The position accounts for 0.02% of the portfolio, ranked #472.
Nomura Holdings first reported a position in RMD in Q2 2013 and has held it in 32 quarters since. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Nomura Holdings held 36,993 shares of ResMed worth $8.3M as of Q1 2026.
- Nomura Holdings bought 11,753 ResMed shares in Q1 2026, an estimated $2.93M.
- ResMed made up 0.02% of Nomura Holdings's portfolio in Q1 2026, its #472 holding.
- Nomura Holdings first reported a position in ResMed in Q2 2013 and has held it in 32 quarters since.
- 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.